NME

Nerdio Unveils Major Upgrades in Nerdio Manager for Enterprise and Nerdio Manager for MSP, Enhancing Both Platforms

Retrieved on: 
Tuesday, April 2, 2024
Microsoft, Vanquis Bank, OS, Automation, BSU, Synthetic media, BDR, Organization, Data as a service, Endpoint, VM, Azure Virtual Desktop, Investment, UAM, MSP, Microsoft Defender Antivirus, NME, Generative, NMM

IT professionals can now experience the power of Generative AI integrated into all of Nerdio's products alongside enhanced automation and proactive optimization features.

Key Points: 
  • IT professionals can now experience the power of Generative AI integrated into all of Nerdio's products alongside enhanced automation and proactive optimization features.
  • Moreover, the expanded management capabilities extend beyond Azure infrastructure, encompassing broad endpoint management and application delivery enhancements.
  • These advancements equip customers with comprehensive tools to streamline operations, boost efficiency, and maximize the value of their IT investments.
  • "As technology evolves, so does Nerdio's commitment to empowering IT professionals worldwide," stated Vadim Vladimirskiy, CEO of Nerdio.

New Meta Entertainment's Dignitas and "Bugha's End Game" Receive Coveted Game Awards Nomination

Retrieved on: 
Wednesday, November 15, 2023
Battle Royale, Love, TGA, IKE, History, NME, The Game, Map, MIKE, Dignitas, Epic Games, The Game Awards, Video game, Entertainment, Fortnite

LOS ANGELES, Nov. 15, 2023 /PRNewswire/ -- "Bugha's End Game," the groundbreaking custom map in Fortnite created by Dignitas, subsidiary of New Meta Entertainment, Inc, ("NME") and world-renowned professional gamer Bugha, has received a prestigious nomination for The Game Awards in the new 'Best in UEFN' category. The nomination comes on the heels of "Bugha's End Game" achieving remarkable success since its release, captivating the gaming community with its innovative gameplay and design.

Key Points: 
  • The nomination comes on the heels of "Bugha's End Game" achieving remarkable success since its release, captivating the gaming community with its innovative gameplay and design.
  • As part of The Game Awards' commitment to honoring excellence in the industry, the nomination reflects "Bugha's End Game"'s exceptional qualities that have resonated with players and industry experts alike.
  • In addition to a jury vote, The Game Awards allows fans to vote for their favorite maps within Fortnite's new TGA Voting hub.
  • You can find the instructions and how to vote for Bugha's End Game here: bit.ly/tgafortnite
    Since its launch, "Bugha's End Game" has welcomed an astonishing 5.1 million unique players into its virtual arena.

HighTide Therapeutics Inc. is Invited to Present at the 7th Edition of the Future Investment Initiative (FII): The New Compass, in Riyadh, Saudi Arabia

Retrieved on: 
Friday, October 27, 2023
Berberine, Ageing, Attention, Future Investment Initiative Institute, AMPK, Conference, Research, Type 2 diabetes, FII, Ursodeoxycholic acid, NME, Quality of life, HighTide, NASH, Insulin resistance, AI, Therapy, Patient, T2DM, Fatty liver disease, Pharmaceutical industry

The rising burden of aging-related diseases has become an urgent global health challenge that requires immediate attention.

Key Points: 
  • The rising burden of aging-related diseases has become an urgent global health challenge that requires immediate attention.
  • Recent advances in anti-aging research and big data empower a more holistic approach to understanding and reversing human aging with evidence suggests that slowing down aging can substantially improve quality of life.
  • The FII Conference, hosted by the Future Investment Initiative (FII) Institute, has been held for seven consecutive years and has developed into one of the most important economic and investment forums in the Middle East.
  • This year's conference (FII7) was attended exclusively by FII Institute members, strategic partners, decision-makers, and international leaders, and is expected to draw 5,000 delegates attending sessions covering a wide variety of issues with global impact.

CARGO Therapeutics Announces Appointment of Ginna Laport, MD, as Chief Medical Officer

Retrieved on: 
Tuesday, October 17, 2023
University, Stanford Cancer Institute, Antibody, Monoclonal antibody, Division, Drug, Research, Trial of the century, Stanford University School of Medicine, MD, Mosunetuzumab, BLA, IND, Health, Biotechnology, Medicine, Disease, Cancer, Patient, BA, Therapy, B-cell lymphoma, CAR, NME, CD22, Publication, SAN, CD19, BMT, Acceleration, Baylor University, B Division (New York City Subway), NIH, Pharmaceutical industry, Nursing, Stanford University, Blood

SAN MATEO, Calif., Oct. 17, 2023 (GLOBE NEWSWIRE) -- CARGO Therapeutics, Inc. (CARGO), a clinical-stage biotechnology company uniquely positioned to advance next generation, potentially curative cell therapies for cancer patients, today announced the appointment of Ginna Laport, MD, as Chief Medical Officer. Dr. Laport is a seasoned biotechnology executive and senior clinical leader. She will serve on the Company’s executive team and will be responsible for providing leadership and direction to guide CARGO’s clinical development strategy and execution, including the advancement of CARGO’s lead candidate, CRG-022, as well as its pipeline of next-generation CAR T-cell therapies for cancer patients. CRG-022 is an autologous CD22 chimeric antigen receptor (CAR) T-cell therapy candidate, currently in a potentially pivotal Phase 2 clinical trial in patients with large B-cell lymphoma (LBCL) whose disease relapsed or was refractory (R/R) to CD19 CAR T-cell therapy.

Key Points: 
  • SAN MATEO, Calif., Oct. 17, 2023 (GLOBE NEWSWIRE) -- CARGO Therapeutics, Inc. (CARGO), a clinical-stage biotechnology company uniquely positioned to advance next generation, potentially curative cell therapies for cancer patients, today announced the appointment of Ginna Laport, MD, as Chief Medical Officer.
  • “We are thrilled to announce the addition of Ginna to our team as Chief Medical Officer.
  • With her extensive leadership background in clinical drug development, particularly in hematology/oncology, she brings invaluable expertise to our organization,” said Gina Chapman, CARGO’s President and Chief Executive Officer.
  • Previously, Dr. Laport was Chief Medical Officer at Tempest Therapeutics, where she directed the clinical development of small molecules that combine both tumor-targeted and immune-mediated mechanisms, including several IND submissions.

New Meta Entertainment Partners with the Ruderman Family Foundation to Support Mental Health in Gaming

Retrieved on: 
Thursday, October 12, 2023
Partnership, Academy Awards, Sport, Ruderman Family Foundation, Fortnite, Performing, Mental health, Education, NME, Dignitas, Esports, Fortnite World Cup, Major League Baseball Players Association, Boston Red Sox, Video game, Nursing, TwitchCon

LOS ANGELES, Oct. 12, 2023 /PRNewswire/ -- New Meta Entertainment, Inc. (NME), the parent company of esports organization Dignitas and women's gaming broadcast production platform Raidiant, has today announced a new partnership with the Ruderman Family Foundation, an internationally recognized organization that works to end the stigma associated with mental health. As the Official Mental Health Partner of NME, the Foundation is partnering with and providing a grant to New Meta Entertainment's Dignitas to enhance an inclusive and supportive environment for gaming fans and esports professionals everywhere.

Key Points: 
  • In addition, New Meta Entertainment and the Foundation will create an event space at TwitchCon where talent and fans can connect with mental health resources.
  • "We are thrilled to welcome the Ruderman Family Foundation to NME as our Official Mental Health Partner, reinforcing our commitment to the gaming community," said Michael Prindiville, CEO of NME.
  • The new partnership sees the Ruderman Family Foundation expand its extensive work within the mental health space, now into gaming.
  • "Despite the severity of today's mental health crisis, far too many Americans sorely lack access to essential mental health resources and services," said Jay Ruderman, President of the Ruderman Family Foundation.

Ethos Discovery and Gallant Therapeutics Collaborate on Study Evaluating Gallant’s Stem Cell Therapy in Pugs with Necrotizing Meningoencephalitis (NME), also referred to as Pug Dog Encephalitis (PDE)

Retrieved on: 
Tuesday, October 3, 2023
Ethos, Linda, Necrotizing meningoencephalitis, Seizure, Human, Survival, Brain, Research, Brain damage, Inflammation, Multiple sclerosis, Doctor of Philosophy, Neck, Microsoft Exchange Server, Back pain, Discovery, HIV disease progression rates, T-cell receptor excision circles, SAN, Lethargy, DSM-IV codes, Dog, Blood, Pet, Simons, Steroid, Genetic testing, Cat, Diagnosis, B cell, Therapy, PDE, Phenotype, Encephalitis, DVM, NME, Gallant, Disease, Neurology, Pharmaceutical industry, Medical imaging

Within 24 hours, Walter was diagnosed with pug dog encephalitis (PDE), a common name for necrotizing meningoencephalitis (NME) because it occurs most commonly in that breed.

Key Points: 
  • Within 24 hours, Walter was diagnosed with pug dog encephalitis (PDE), a common name for necrotizing meningoencephalitis (NME) because it occurs most commonly in that breed.
  • Despite aggressive therapy with steroids, immunosuppressants, and anti-seizure medications, Walter died within 24 hours of his diagnosis.
  • In this third study in the program, Ethos Discovery and Gallant Therapeutics are investigating treatment with Gallant’s MSCs in pugs previously screened for NME.
  • To learn more about enrolling your pug in the study, please visit: https://www.ethosdiscovery.org/clinical-study/necrotizing-meningoencepha....

North America - Healthcare Logistics Market size to grow by USD 18.4 billion from 2022 to 2027, Legislative and regulatory changes supporting pharma growth to drive the growth - Technavio

Retrieved on: 
Monday, October 2, 2023
Vaccine, CDER, Industrial internet of things, Data wrangling, CMA, Biopharmaceutical, Center for Drug Evaluation and Research, Augmented reality, Intelligent automation, United Van Lines, AmerisourceBergen, DSV, Automation, YOY, USD, FedEx, Government, Free, Digital electronics, Air Canada, Nippon Yusen, Investment, Nature, United Parcel Service, Fourth Industrial Revolution, Deutsche Bahn, Virtual reality, Local government in Canada, Artificial intelligence, Growth, Transport, FDA, Industrial, R, Criticism of the Food and Drug Administration, Food, NME, Deutsche Post DHL Group, Pharmaceutical industry, Beauty salon, Fine chemical, Research

NEW YORK, Oct. 2, 2023 /PRNewswire/ -- The North America healthcare logistics market is expected to grow by USD 18.4 billion from 2022 to 2027.

Key Points: 
  • NEW YORK, Oct. 2, 2023 /PRNewswire/ -- The North America healthcare logistics market is expected to grow by USD 18.4 billion from 2022 to 2027.
  • The adoption of legislative and regulatory changes supporting pharma growth is the key factor driving the market growth.
  • The report analyses the market size and growth and provides accurate predictions on the growth of the market.
  • The healthcare logistics market is estimated to grow at a CAGR of 11.67% between 2022 and 2027.

GamerTech® Named Official Performance Wearable and Apparel Partner of Dignitas

Retrieved on: 
Monday, September 18, 2023
Rocket League, Partnership, Posture, League, MAS, Organization, Athlete, The Co Founder, Longevity, Health, Dignitas, NME, Video game, Fortnite

LOS ANGELES, Sept. 18, 2023 /PRNewswire/ -- Dignitas, the esports vertical of New Meta Entertainment, Inc. (NME), has today announced a new partnership with GamerTech®, a designer and manufacturer of performance wearables and advanced apparel solutions for gamers. As Dignitas's Official Performance Wearable and Apparel Partner, GamerTech® will further enhance the gaming experience, building upon their past collaborations with various esports organizations, scientists, and industry experts.

Key Points: 
  • As Dignitas's Official Performance Wearable and Apparel Partner, GamerTech® will further enhance the gaming experience, building upon their past collaborations with various esports organizations, scientists, and industry experts.
  • As part of this partnership, Dignitas and GamerTech® will collaborate on co-branded performance wear.
  • GamerTech® will work with Dignitas to massively increase their reach and help get their products into the hands of gamers worldwide.
  • "We at Dignitas have always been committed to not only achieving peak performance but also ensuring the well-being of our players," stated James Baker, Dignitas' General Manager.

Exploring the Demodex Blepharitis Market: Clinical Viewpoints, Pipeline Evaluation, and Market Access Services | Disease Landscape Insights

Retrieved on: 
Monday, September 11, 2023
Infection, Pharma, Chalazion, Eyelash, Ocular rosacea, Signs and symptoms, Research, Inflammation, IgG4-related ophthalmic disease, Causes, Eyelid, DLI, Biological soil crust, Immune system, Growth, MITES, Ageing, Patient, Itch, Diagnosis, Stye, Meibomian gland dysfunction, Gland, FDA, R, Red, NIH, Skin, NME, Disease, Cosmetics, Agriculture, Medical device, Pharmaceutical industry, Demodex

Demodex Blepharitis is an inflammatory eye disorder caused by the uncontrollable growth of tiny mites known as Demodex on our eyelids.

Key Points: 
  • Demodex Blepharitis is an inflammatory eye disorder caused by the uncontrollable growth of tiny mites known as Demodex on our eyelids.
  • We at Disease Landscape Insights (DLI) aim to assist our clientele in understanding the characteristics of this disease and help them develop cutting edge treatment solutions.
  • Unlocking Insights into Demodex Blepharitis – From Research to Treatment Solutions, Dive Deeper into Managing this Eye Condition.
  • According to a data released by NIH, around 41% to 70% of the world's population are affected or highly prone to Demodex Blepharitis .

Healthcare Logistics Market to increase by USD 87.9 billion during 2022 to 2027; Growing global pharmaceutical sales to drive the growth- Technavio

Retrieved on: 
Tuesday, September 5, 2023
Vaccine, CDER, Medicine, FDA Center for Devices and Radiological Health, Center for Drug Evaluation and Research, Health care, Medication, AmerisourceBergen, DSV, Transport, YOY, USD, DB Schenker, FedEx, Plasma protein binding, Internet, Incidence, Air Canada, Patient, Nature, United Parcel Service, Agility, United States Secretary of Labor, Conditional sentence, Growth, McKesson Corporation, PDF, CEVA Logistics, SF Express, Deployment, NME, Deutsche Post DHL Group, Pharmaceutical industry, Pet industry, Geography, Research

NEW YORK, Sept. 5, 2023 /PRNewswire/ -- The healthcare logistics market size is expected to grow by USD 87.9 billion between 2022 and 2027.

Key Points: 
  • NEW YORK, Sept. 5, 2023 /PRNewswire/ -- The healthcare logistics market size is expected to grow by USD 87.9 billion between 2022 and 2027.
  • The report analyses the market size and growth and provides accurate predictions on the growth of the market.
  • View a PDF Sample
    Growing global pharmaceutical sales drives the growth of the healthcare logistics market.
  • The growth of the global market can be attributed to factors such as the growing geriatric population and new product launches by pharmaceutical manufacturers.